3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2

Sets of 3-alkenyl-2-oxindoles were synthesized of potential antiproliferative (against PaCa-2 and MCF7cancer cell lines) and promising properties against SARS-CoV-2. [Display omitted] •3-Alkenyl-2-oxindoles were prepared in a facile synthetic pathway.•The synthesized agents show potent properties ag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2021-09, Vol.114, p.105131-105131, Article 105131
Hauptverfasser: Girgis, Adel S., Panda, Siva S., Srour, Aladdin M., Abdelnaser, Anwar, Nasr, Soad, Moatasim, Yassmin, Kutkat, Omnia, El Taweel, Ahmed, Kandeil, Ahmed, Mostafa, Ahmed, Ali, Mohamed A., Fawzy, Nehmedo G., Bekheit, Mohamed S., Shalaby, ElSayed M., Gigli, Lara, Fayad, Walid, Soliman, Ahmed A.F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sets of 3-alkenyl-2-oxindoles were synthesized of potential antiproliferative (against PaCa-2 and MCF7cancer cell lines) and promising properties against SARS-CoV-2. [Display omitted] •3-Alkenyl-2-oxindoles were prepared in a facile synthetic pathway.•The synthesized agents show potent properties against PaCa2 cell line.•CAM assay reveals the anti-angiogenic properties of the targeted agents.•The agents synthesized show multi-targeted inhibitory properties against VEGFR-2 and c-kit.•Antiviral properties against SARS-CoV-2 and high SI were revealed by the synthesized agents. Sets of 3-alkenyl-2-oxindoles (6,10,13) were synthesized in a facile synthetic pathway through acid dehydration (EtOH/HCl) of the corresponding 3-hydroxy-2-oxoindolines (5,9,12). Single crystal (10a,c) and powder (12a,26f) X-ray studies supported the structures. Compounds 6c and 10b are the most effective agents synthesized (about 3.4, 3.3 folds, respectively) against PaCa2 (pancreatic) cancer cell line relative to the standard reference used (Sunitinib). Additionally, compound 10b reveals antiproliferative properties against MCF7 (breast) cancer cell with IC50 close to that of Sunitinib. CAM testing reveals that compounds 6 and 10 demonstrated qualitative and quantitative decreases in blood vessel count and diameter with efficacy comparable to that of Sunitinib, supporting their anti-angiogenic properties. Kinase inhibitory properties support their multi-targeted inhibitory activities against VEGFR-2 and c-kit in similar behavior to that of Sunitinib. Cell cycle analysis studies utilizing MCF7 exhibit that compound 6b arrests the cell cycle at G1/S phase while, 10b reveals accumulation of the tested cell at S phase. Compounds 6a and 10b reveal potent antiviral properties against SARS-CoV-2 with high selectivity index relative to the standards (hydroxychloroquine, chloroquine). Safe profile of the potent synthesized agents, against normal cells (VERO-E6, RPE1), support the possible development of better hits based on the attained observations.
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2021.105131